chr19-11399874-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001035223.4(RGL3):c.1727C>T(p.Pro576Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000133 in 1,503,670 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001035223.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGL3 | NM_001035223.4 | c.1727C>T | p.Pro576Leu | missense_variant | 16/19 | ENST00000380456.8 | NP_001030300.3 | |
RGL3 | NM_001161616.3 | c.1745C>T | p.Pro582Leu | missense_variant | 16/19 | NP_001155088.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGL3 | ENST00000380456.8 | c.1727C>T | p.Pro576Leu | missense_variant | 16/19 | 1 | NM_001035223.4 | ENSP00000369823.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 2AN: 166492Hom.: 0 AF XY: 0.0000223 AC XY: 2AN XY: 89730
GnomAD4 exome AF: 0.0000141 AC: 19AN: 1351454Hom.: 0 Cov.: 31 AF XY: 0.0000166 AC XY: 11AN XY: 662250
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 06, 2023 | The c.1745C>T (p.P582L) alteration is located in exon 16 (coding exon 16) of the RGL3 gene. This alteration results from a C to T substitution at nucleotide position 1745, causing the proline (P) at amino acid position 582 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at